Paul Schimmel | |
---|---|
Born | [1] Hartford, Connecticut | August 4, 1940
Education | Ohio Wesleyan University (B.A.) Massachusetts Institute of Technology (Ph.D.) |
Awards | Pfizer Award in Enzyme Chemistry (1978); Emily M. Gray Award for Significant Contributions to Education in Biophysics; Stein and Moore Award of the Protein Society; Kathryn C. Hach Award for Entrepreneurial Success |
Scientific career | |
Fields | Biochemistry/Molecular Medicine |
Doctoral students | Maria Jasin, Lynne Regan |
Paul Reinhard Schimmel (born August 4, 1940) is an American biophysical chemist and translational medicine pioneer.
Paul Schimmel is a Professor of Molecular Medicine [2] at The Scripps Research Institute. Prior to joining The Scripps Research Institute, he was a John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics at MIT (Massachusetts Institute of Technology). Author or coauthor of many scientific research publications, [3] he is also coauthor of a widely used 3-volume textbook on biophysical chemistry. [4] His research interests have focused on aminoacyl tRNA synthetases as fundamental interpreters of the genetic information. [5] Through career-long investigations of this ancient and universal set of essential enzymes, his laboratory has worked on a universal mechanism for correcting errors in the interpretation of genetic information, [6] [7] and went on to show how this mechanism is essential for maintaining cellular homeostasis and for preventing serious pathologies and disease. [8] [9] He has also been listed as one of the leading translational researchers in the world, having one of the top five most cited patents for the period 2012-2016. [10]
His laboratory also discovered what others have referred to as a tRNA synthetase-directed primordial, or 'second', genetic code that eventually was incorporated into the modern code. [11] [12] [13] In a separate line of research published back in 1983, Schimmel developed the concept of what are now known as ESTs (expressed sequence tags) and the strategy of shotgun sequencing, approaches that several years later were adopted for the human genome project. [14] Nature magazine listed Schimmel's work on the development of ESTs as one of the four key developments that launched the human genome project. [15] Lastly, his laboratory established connections of synthetases to disease and, most recently, they reported the structural and functional metamorphosis of these proteins, whereby they are repurposed with novel activities, both inside and outside the cell, in a variety of cell signaling pathways [16] [17] [18]
Named to various society and university awards and honorary degrees, and elected to membership in the American Academy of Arts and Sciences, [19] the National Academy of Sciences, [20] the American Philosophical Society, [21] the Institute of Medicine (National Academy of Medicine) [22] and National Academy of Inventors. [23] Active in many scientific and academic organizations and committees, including past service as President of the Division of Biological Chemistry of the American Chemical Society (presently with over 7,000 members) and as an editorial board member of numerous scientific journals. In June 2020, he was named the 2020 winner of the Kathryn C. Hach Award for Entrepreneurial Success for "co-founding more than ten biotech companies and aiding others in their endeavors for nearly three decades." [24] Named the ARCS San Diego Chapter 2020 Scientist of the Year [25]
Transfer RNA is an adaptor molecule composed of RNA, typically 76 to 90 nucleotides in length. In a cell, it provides the physical link between the genetic code in messenger RNA (mRNA) and the amino acid sequence of proteins, carrying the correct sequence of amino acids to be combined by the protein-synthesizing machinery, the ribosome. Each three-nucleotide codon in mRNA is complemented by a three-nucleotide anticodon in tRNA. As such, tRNAs are a necessary component of translation, the biological synthesis of new proteins in accordance with the genetic code.
An aminoacyl-tRNA synthetase, also called tRNA-ligase, is an enzyme that attaches the appropriate amino acid onto its corresponding tRNA. It does so by catalyzing the transesterification of a specific cognate amino acid or its precursor to one of all its compatible cognate tRNAs to form an aminoacyl-tRNA. In humans, the 20 different types of aa-tRNA are made by the 20 different aminoacyl-tRNA synthetases, one for each amino acid of the genetic code.
Aminoacyl-tRNA is tRNA to which its cognate amino acid is chemically bonded (charged). The aa-tRNA, along with particular elongation factors, deliver the amino acid to the ribosome for incorporation into the polypeptide chain that is being produced during translation.
Alexander Rich was an American biologist and biophysicist. He was the William Thompson Sedgwick Professor of Biophysics at MIT and Harvard Medical School. Rich earned an A.B. and an M.D. from Harvard University. He was a post-doc of Linus Pauling. During this time he was a member of the RNA Tie Club, a social and discussion group which attacked the question of how DNA encodes proteins. He has over 600 publications to his name.
Charles R. Cantor is an American molecular geneticist who, in conjunction with David Schwartz, developed pulse field gel electrophoresis for very large DNA molecules. Cantor's three-volume book Biophysical Chemistry, co-authored with Paul Schimmel, was an influential textbook in the 1980s and 1990s.
Elongation factor 1-delta is a protein that in humans is encoded by the EEF1D gene.
Glycine—tRNA ligase also known as glycyl–tRNA synthetase is an enzyme that in humans is encoded by the GARS1 gene.
Tyrosine—tRNA ligase, also known as tyrosyl-tRNA synthetase is an enzyme that is encoded by the gene YARS. Tyrosine—tRNA ligase catalyzes the chemical reaction
Tryptophanyl-tRNA synthetase, cytoplasmic is an aminoacyl-tRNA synthetase enzyme that attaches the amino acid tryptophan to its cognate tRNA. In humans, it is encoded by the WARS gene.
Elongation factor 1-beta is a protein that in humans is encoded by the EEF1B2 gene.
Tyrosyl-tRNA synthetase, cytoplasmic, also known as Tyrosine-tRNA ligase, is an enzyme that in humans is encoded by the YARS gene.
Leucyl-tRNA synthetase, cytoplasmic is an enzyme that in humans is encoded by the LARS gene.
Valyl-tRNA synthetase is an enzyme that in humans is encoded by the VARS gene.
Amino acid activation refers to the attachment of an amino acid to its respective transfer RNA (tRNA). The reaction occurs in the cell cytosol and consists of two steps: first, the enzyme aminoacyl tRNA synthetase catalyzes the binding of adenosine triphosphate (ATP) to a corresponding amino acid, forming a reactive aminoacyl adenylate intermediate and releasing inorganic pyrophosphate (PPi). Subsequently, aminoacyl tRNA synthetase binds the AMP-amino acid to a tRNA molecule, releasing AMP and attaching the amino acid to the tRNA. The resulting aminoacyl-tRNA is said to be charged.
Olke C. Uhlenbeck is a Professor Emeritus of Biochemistry at the University of Colorado Boulder and at Northwestern University.
Susan L. Ackerman is an American neuroscientist and geneticist. Her work has highlighted some of the genetic and biochemical factors that are involved in the development of the central nervous system and age-related neurodegeneration. Her research is aimed at helping scientists understand what causes several types of neurodegeneration in mammals. This research, and others' like it, may lead to cures for neurodegenerative diseases. Ackerman is a professor at University of California San Diego. She was formerly a professor at the Jackson Laboratory and the Sackler School of Graduate Biomedical Sciences at Tufts University. She also serves as an adjunct professor at the University of Maine, Orono. Ackerman was an associate geneticist at Massachusetts General Hospital in Boston, Massachusetts.
Nenad Ban is a biochemist born in Zagreb, Croatia who currently works at the ETH Zurich, Swiss Federal Institute of Technology, as a professor of Structural Molecular Biology. He is a pioneer in studying gene expression mechanisms and the participating protein synthesis machinery.
Susan A. Martinis is an American biochemist. She has co-authored over 57 publications in peer reviewed journals and scientific book chapters. Her expertise is in protein:RNA interactions and aminoacyl tRNA synthetases. As of 2019, she is the Vice Chancellor for Research and Innovation at the University of Illinois at Urbana-Champaign.
Xiang-Lei Yang (杨湘磊) is a Chinese-born American molecular biologist. She is a professor at The Scripps Research Institute, located in La Jolla, California. Her work has contributed to the establishment of physiological importance of aminoacyl-tRNA synthetases beyond their classical role in supporting mRNA translation and their disordered processes that contribute to disease. She founded the Translation Machinery in Health and Disease Gordon Research Conference, an ongoing biannual international conference since 2015. She helped co-found aTyr Pharma, a Nasdaq-listed biotechnology company.
William H. McClain is an American molecular biologist and academic. He was the Halvorson Professor of Bacteriology and Molecular Biology, at the University of Wisconsin-Madison. McClain is a Fellow of the American Academy of Arts and Sciences, and, formerly, a Jane Coffin Childs Memorial Fund for Medical Research Fellow. He was a Board Member of the American Academy of Arts and Sciences, Midwest Center. McClain is a pioneer in the biological sciences known for the dissection of RNA-protein recognition primarily through genetic and biochemical means in bacteria.